Hélène Le Buanec

Title: Hélène Le Buanec: Innovator in Immunogenic Products

Introduction

Hélène Le Buanec is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the development of stable immunogenic products. With a total of three patents to his name, Le Buanec's work is recognized for its innovative approaches to vaccine preparation.

Latest Patents

Le Buanec's latest patents include a method for preparing a stable TNF-α vaccine. This invention focuses on creating a stable immunogenic product that induces antibodies against one or more antigenic proteins. The product is characterized by proteinaceous immunogenic heterocomplexes formed through associations between antigenic protein molecules and proteinaceous carrier molecules. Notably, less than 40% of the antigenic proteins are linked to the carrier molecules by a covalent bond. Another significant patent involves a method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF-α and a carrier protein, detailing the method steps in the specification.

Career Highlights

Le Buanec is currently associated with Neovacs, a company focused on developing innovative therapeutic solutions. His work at Neovacs has been instrumental in advancing the understanding and application of immunogenic products.

Collaborations

Throughout his career, Le Buanec has collaborated with notable colleagues, including Daniel Zagury and Bernard Bizzini. These collaborations have contributed to the success and impact of his inventions in the field of immunology.

Conclusion

Hélène Le Buanec stands out as an influential inventor in the realm of immunogenic products. His innovative patents and contributions to vaccine development highlight his commitment to advancing medical science.